Experien was the consultant RAP engaged in an attempt to gain FDA approval. Experien's track record was almost perfect which in part drove RAP's SP to our all time highs. Price crashed when FDA wasn't greenlit.
Any punter who has performed the most basic of due diligence would've been aware of this. Surely if one were to invest in a company; one would investigate the cause of said company's largest SP drop. Good thing you did no research on the business you invested in, poked your beak in out of nowhere and claim to know what you're taking about. Unfortunately, now the entire forum is acutely aware of your ignorance but that's ok cos you're a "serious investor".
RAP Price at posting:
18.5¢ Sentiment: None Disclosure: Held